These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23170305)

  • 1. The use of clobazam as an adjunctive treatment for Lennox-Gastaut syndrome.
    Owen RT
    Drugs Today (Barc); 2012 Nov; 48(11):697-703. PubMed ID: 23170305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clobazam : in patients with Lennox-Gastaut syndrome.
    Yang LP; Scott LJ
    CNS Drugs; 2012 Nov; 26(11):983-91. PubMed ID: 23034582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobazam approved for seizure disorder.
    Traynor K
    Am J Health Syst Pharm; 2011 Dec; 68(23):2204. PubMed ID: 22095800
    [No Abstract]   [Full Text] [Related]  

  • 4. Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.
    Seif-Eddeine H; Ng YT
    Expert Rev Neurother; 2012 Apr; 12(4):385-93. PubMed ID: 22449211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobazam (Onfi) for Lennox-Gastaut syndrome.
    Med Lett Drugs Ther; 2012 Mar; 54(1385):18-9. PubMed ID: 22382580
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.
    Ng YT; Conry JA; Drummond R; Stolle J; Weinberg MA;
    Neurology; 2011 Oct; 77(15):1473-81. PubMed ID: 21956725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clobazam, ezogabine, and tafluprost.
    Hussar DA; Hallinan SE
    J Am Pharm Assoc (2003); 2012; 52(4):546-50. PubMed ID: 22825237
    [No Abstract]   [Full Text] [Related]  

  • 8. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
    Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
    Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome.
    Tolbert D; Harris SI; Bekersky I; Lee D; Isojarvi J
    Epilepsy Behav; 2014 Aug; 37():11-5. PubMed ID: 24949576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study.
    Ng YT; Conry J; Paolicchi J; Kernitsky L; Mitchell W; Drummond R; Isojarvi J; Lee D; Owen R;
    Epilepsy Behav; 2012 Dec; 25(4):687-94. PubMed ID: 23141144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome.
    Clements KM; Skornicki M; O'Sullivan AK
    Epilepsy Behav; 2013 Oct; 29(1):184-9. PubMed ID: 23973644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clobazam for treatment of epilepsy.
    Giarratano M; Standley K; Benbadis SR
    Expert Opin Pharmacother; 2012 Feb; 13(2):227-33. PubMed ID: 22242724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Lennox-Gastaut syndrome.
    Hancock EC; Cross JH
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome.
    Paolicchi JM; Ross G; Lee D; Drummond R; Isojarvi J
    Pediatr Neurol; 2015 Oct; 53(4):338-42. PubMed ID: 26245776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
    Wier HA; Cerna A; So TY
    Paediatr Drugs; 2011 Apr; 13(2):97-106. PubMed ID: 21351809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.
    de Leon J; Spina E; Diaz FJ
    Ther Drug Monit; 2013 Feb; 35(1):30-47. PubMed ID: 23318278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
    Lee EH; Yum MS; Choi HW; Ko TS
    Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.